Skip to main content

Closed

ESPR: Esperion Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

67thpctl

Volume

-

Market Cap

661.15MUSD

P/E Ratio

-131.4TTM

Div Yield

99.37%ann

Esperion Therapeutics, Inc.

ESPRNASDAQ Global Market·USD·Closed

Esperion Therapeutics, Inc.

ESPRNASDAQ·USD·Closed

$3.18

+0.00%

$3.18

+$0.00 (0.00%)

52W Range

67thpctl

Volume

-

Mkt Cap

661.15MUSD

P/E

-131.4TTM

Div Yield

99.37%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings